¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nil lesion disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • McArdle¡¯s disease
    ¸Æ¾Æµéº´
  • medullary cystic disease
    ¼ÓÁú³¶º´, ¼öÁú³¶¼ºº´
  • Menetrier disease
    ¸Þ³×Æ®¸®¿¡º´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metazoan disease
    ÈÄ»ýµ¿¹°º´
  • microdrepanocytic disease
    ÀÛÀº³´ÀûÇ÷±¸º´
  • neoplastic disease
    ½Å»ý¹°º´, Á¾¾çº´
  • nervous disease
    ½Å°æ°èÁúȯ, ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±Ù(À°)º´
  • neuropathic joint disease
    ½Å°æº´¼º°üÀýº´
  • notifiable disease
    ½Å°í´ë»óº´, ¹ß»ýº¸°íº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • nutritional disease
    ¿µ¾çº´, ¿µ¾ç¼ºÁúȯ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üº´, Æó¼â³úÇ÷°üÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • pandemic disease
    ¹üÀ¯Çິ
  • panzootic disease
    µ¿¹°¹üÀ¯Çິ
  • parasitic disease
    ±â»ýÃæº´
  • paroxysmal disease
    ¹ßÀÛº´
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
  • periapical disease
    Ä¡±Ù´ÜÁÖÀ§º´, Ä¡¾Æ³¡ÁÖÀ§º´
  • pericardial disease
    ½ÉÀ帷º´
  • periodontal disease
    Ä¡ÁÖº´, Ä¡±Ù¸·º´
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üº´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°»çº´
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸ÓÁõ
  • polycystic kidney disease
    ¹µÁÖ¸Ó´ÏÄáÆÏº´, ´Ù³¶ÄáÆÏº´
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ鿪Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • grinder s disease ; silicosis
    ±ÔÆóÁõ.
  • hallervoden-spatz disease
    ÇÒ·¯º¸µç-½´ÆÄÂê º´, Hallervoden-Spatz º´
  • hand and foot disease
    ¼ö Á· Áúȯ£¨â¢ðëòðü´£©£¬¼Õ ¹ß º´, ¼ö Á· º´ (â¢ðëÜ»).
  • hand foot and mouth disease
    ¼Õ¹ßÀÔº´ (¡­Ü»), ¼öÁ·±¸º´(â¢ðëϢܻ).
  • hand foot and mouth disease
    ¼Õ¹ßÀÔº´ (¡­Ü»), ¼öÁ·±¸º´(â¢ðëϢܻ)
  • hand-foot-mouth disease
    ¼öÁ·±¸º´
  • hand-schueller-christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÂùº´
  • hanseniasis = Hansens disease
    ÇѼ¾º´
  • hansens disease
    ÇѼ¾ º´, Hansen º´
  • hard pad disease
    °æÃ´Áõ(Ìãô²ñø).
  • hartnup disease
    ÇÏ¾ÆÆ®´¯ º´, Hartnup º´
  • heart disease
    ½ÉÁúȯ(ãýòðü´), ½ÉÀ庴(ãýíôÜ»).
  • heart muscle disease
    ½É±ÙÁúȯ(ãýÐÉòðü´)
  • heart water disease
    ½É¼öº´(ãýâ©Ü»).
  • heavy chain disease
    H¼âº´(¡­áðÜ»), Á߼⺴(ñìáðÜ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • cystine disease
    ½Ã½ºÆ¾º´(¡­Ü»).
  • cystine storage disease
    ½Ã½ºÆ¾(ÃàÀû)º´ (¡­õëîÝÜ»).
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë ºÀÀÔü º´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÈ­ ºÀÀÔüº´
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    °Å´ë¼¼Æ÷ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =cid
    °Å´ë¼¼Æ÷¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(¡­òðü´)
  • degenerative brain disease
    ÅðÇ༺ ³úÁúȯ.
  • degenerative brain disease
    ÅðÇ༺ ³úÁúº´(÷Üú¼àõ ÒàòðÜ»).
  • degenerative disease
    ÅðÇ༺ Áúȯ.
  • degenerative heart disease
    ÅðÇ༺ ½ÉÁúȯ.
  • degenerative joint disease
    ÅðÇ༺ °üÀý Áúȯ(÷Üú¼àõμï½.
  • degenerative joint disease
    ÅðÇ༺ °üÀýÁúȯ(¡­Î¼ï½òðü´)
  • dejerine-sottas disease
    µ¥Àú¸°-¼ÒŸ½ºº´ (¡­Ü»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
MDV Marek disease virus; mean dye [bolus] velocity; mucosal disease virus
MJD Machado-Joseph disease; Mseleni joint disease
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
MVD Doctor of Veterinary Medicine; microvascular decompression; mitral valve disease; multivessel corona...
NAD neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
CBDC Chronic bullous disease of childhood
cGVHD Chronic graft versus host disease
cGVHD Chronic graft-vs.-host disease
CIBD Chronic inflammatory bowel disease
CLD Chronic liver disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Paget's disease
    ÆÄ°Ù º´, ÆÄÁ¬ Áúȯ, ÆÄÁ¦Æ®º´, º¯Çü¼º °ñ¿°, ÆäÀÌÁ¬¾¾ º´
    1. Çϳª³ª ȤÀº ¿©·¯ °ñÀÇ ¿°ÁõÀ» µ¿¹ÝÇÏ´Â ¿øÀÎ ºÒ¸íÀÇ Àå¾Ö·Î¼­ ¹«Á¶Á÷¼º °ñ ȸº¹À» µ¿¹ÝÇÏ´Â °ñÀÇ ºñÈÄ¿Í ¿¬È­¸¦ ÀÏÀ¸Å²´Ù. 2. À¯¹æÀÇ Pagetº´Àº ¸¸¼º ½ÀÁø°ú À¯»çÇÏ°í ¾ÆÆ÷Å©¸°¼±ÀÌ ¸¹Àº ºÎÀ§¿¡ »ý±ä´Ù. Ç×¹® ÁÖÀ§¿¡ »ý±â´Â °Íº¸´Ù´Â ¿ÜÀ½ºÎ¿¡ »ý±â´Â °Í¿¡¼­ µ¿¹ÝµÈ ÇѼ± ¾ÏÀÌ ÀÖÀ» È®·üÀÌ ¸¹´Ù. À¯¹æÀÇ Pagetº´Àº ÀÏÃø¼º ¶Ç´Â µå¹°°Ô ¾çÃø¼ºÀ¸·Î ¿À´Â È«¹Ý¼º Àμ³¼º ÆÇÀ¸·Î Áø¹°ÀÌ ³¯ ¼ö ÀÖÀ¸¸ç ¶§¶§·Î À¯¹æ¾ÏÀÌ µ¿¹ÝµÈ´Ù. 3. °ñÀÇ ÀÌÇü¼º ÁúȯÀ¸·Î 40´ë ÈĹÝ, ³²¼º¿¡ ´õ ¸¹À¸³ª, ¿©¼º¿¡¼­ ´õ ½ÉÇÏ´Ù. ´Ù°ñ¼ºÀ¸·Î »êÀçÇÏ¿© Àå°ñ°ú ôÃß¿¡ ½ÉÇÑ º´º¯À» ¾ß±âÇÏ¿© º¯Çü°ú ºÒ±¸°¡ µÈ´Ù. µÎ°³°ñ°ú »ó¾Ç°ñÀÌ °úµµÇÏ°Ô ¼ºÀåÇϸç, ¶§·Î´Â ÇϾǰñÀÇ °úµµ ¼ºÀåµµ ÀϾ´Ù. 4. ÆÄ°ñ ¼¼Æ÷¿Í °ñ¸ð ¼¼Æ÷ Ȱ¼ºÀÌ Á¶È­¸¦ ÀÌ·çÁö ¸øÇϸ鼭 Å©±â´Â Ä¿ÁöÁö¸¸ ´õ ¾àÇÑ °ñÀ» ¸¸µå´Â ³ªÀÌµç ¼ºÀο¡¼­ ¹ß»ýÇÏ´Â ÁúȯÀ¸·Î µ¿ÅëÀÌ ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³ª¸ç, Ç÷û ¾ËÄ«¸®¼º Àλê È¿¼Ò¿Í ÇÏÀ̵å·Ï½Ã ÇÁ·Ñ¸°ÀÌ Áõ°¡µÇ°í ¾Ç¼º °ñ Á¾¾çÀ¸·Î ¹ßÀüÇÒ °¡´É¼ºÀÌ ³ô´Ù.
  • pandemic disease
    ¹üÀ¯Ç༺ º´
    ±¤¹üÀ§ÇÏ°Ô ÆÛÁ® ¹ß»ýÇÑ À¯Ç༺ Áúȯ.
  • Parkinsonian disease
    ÆÄŲ½¼¾¾ º´
    1. ¹«¿îµ¿Áõ, ÁøÀü, ±Ù °æÁ÷ÀÌ Æ¯Â¡ÀûÀÎ ½Å°æ Àå¾ÖÀÇ 1±º. 2. Á¤ÁöÇϰí ÀÖÀ» ¶§´Â ÁøÀüÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ÁøÀü ¸¶ºñ.
  • pearl disease
    ÁøÁÖº´
    °¡ÃàÀÇ º¹¸· ¹× Àå°£¸· °áÇÙ.
  • pearl-worker's disease
    ÁøÁÖ°ø º´
    °ñ ºñ´ë¸¦ ¼ö¹ÝÇÏ´Â ¹Ýº¹¼º ¿°ÁõÀ¸·Î¼­, ÁøÁÖ ºÐ¸» ¶Ç´Â ¸ÕÁö°¡ ÀÖ´Â Àå¼Ò¿¡¼­ ÀÏÇÏ´Â »ç¶÷µé¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù.
  • Pellegrini's disease
    Æç·¹±×¸®´Ï º´
    ¹«¸­ÀÇ ³»º¹ÃøºÎ Àδë À§¿¡¼­ ¹Ý¿ù»ó °ñ Çü¼ºÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ¸·Î¼­ ¿Ü»ó¼º Àü½Å Àå¾Ö°¡ ¿øÀÎÀÌ´Ù.
  • pelvic inflammatory disease
    °ñ¹Ý¿° Áúȯ
  • peptic ulcer disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
  • peptic ulcerative disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
    Á¤¼­ÀûÀÎ ½ºÆ®·¹½º, ƯÀÌÇÑ À½½Äµé°ú ´Ù¸¥ Á¾·ùÀÇ Àڱص鿡 ÀÇÇØ °úµµÇÑ À§ »êÀÇ ºÐºñ¿¡ ÀÇÇÑ´Ù°í ¹Ï¾îÁø´Ù. °úµµÇÑ ÃâÇ÷, ºóÇ÷, õ°ø µîÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼öµµ ÀÖ´Ù.
  • periapical disease
    Ä¡±Ù´Ü ÁÖÀ§ Áúȯ
  • pericardial disease
    ½É³¶ Áúȯ, ½É¸· Áúȯ
  • periodontal disease
    Ä¡ÁÖ Áúȯ
  • peripheral vascular disease
    ¸»ÃÊÇ÷°ü Áúȯ
  • Perrin-Ferraton disease
    Æä·©-Æä¶óÅë º´
    µ¿ÀǾî=sna
  • Perthes' disease
    Æä¸£Å×½ºº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
Marie-Strumpell disease <rheumatology> A polyarthritis involving the spine, which is characterised by progressive, painful stiffening of the joints and ligaments. It almost exclusively affects young men.
Interestingly the disease seems to be associated with HLA B27, those with this histocompatability antigen are 300 times more likely to get the disease, 90% of sufferers have HLA B27
(18 Nov 1997)
Marion's disease A congenital obstruction of the posterior urethra.
(05 Mar 2000)
Recklinghausen's disease of bone Rarefying osteitis with fibrous degeneration and formation of cysts, and with the presence of fibrous nodules on the affected bones. It is due to marked osteoclastic activity secondary to hyperfunction of the parathyroid glands.
(12 Dec 1998)
Recklinghausen's disease type I type 2 neurofibromatosis
Gerhardt-Mitchell disease Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.
(12 Dec 1998)
Gerhardt's disease Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.
(12 Dec 1998)
vertebral-basilar artery disease <cardiology> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch.
These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
Gerlier's disease A paroxysmal attack of severe vertigo, not accompanied by deafness or tinnitus, which affects young to middle-aged adults, often following a non-specific upper respiratory infection; due to unilateral vestibular dysfunction.
Synonym: endemic paralytic vertigo, epidemic vertigo, Gerlier's disease, kubisagari, kubisagaru, paralyzing vertigo.
(05 Mar 2000)
Martin's disease A periosteoarthritis of the foot from excessive walking.
(05 Mar 2000)
Carrington's disease <radiology> Idiopathic, associated with allergies and desensitization, variant of Loeffler pneumonia, treatment: corticosteroids Findings: reverse pulmonary oedema pattern (= Loeffler's), areas of consolidation persists (days to weeks) see: eosinophilic lung disease
(12 Dec 1998)
Carrion's disease A generalised, acute, febrile, endemic, and systemic form of bartonellosis; marked by high fever, rheumatic pains, progressive, severe anaemia, and albuminuria.
Synonym: Carrion's disease.
(05 Mar 2000)
gestational trophoblastic disease (choriocarcinoma, molar pregnancy) a type of cancer associated with pregnancy in which a grape-like mole develops in the womb instead of a foetus.
(16 Dec 1997)
parkinson disease Progressive, degenerative disease of unknown aetiology characterised by rhythmic tremor of the limbs, stooped posture, slowness of voluntary movements, and masklike facial expression. Pathologically there is nerve cell loss in the melanin-containing cells in the brainstem and a corresponding reduction in dopamine levels in the corpus striatum. Lewy bodies are present in the substantia nigra and locus coeruleus.
(12 Dec 1998)
parkinson disease, postencephalitic A form of parkinson disease due to degeneration of the corpus striatum or substantia nigra, frequently occurring as a sequel of lethargic encephalitis. The early age of onset, the rapid progression of symptoms and signs of stabilization, and the presence of a variety of other neurological disorders (sociopathic behaviour, tics, spasms, oculogyric crises and other restricted motor disorders, breathing arrhythmias, hyperphagia, and bizarre movements, postures, and gaits) distinguish this disease from the one described by parkinson.
(12 Dec 1998)
parkinson disease, symptomatic Symptoms of parkinson disease induced by drugs, or following cerebral arteriosclerosis, brain tumour, or other central nervous system disorders except encephalitis, which is parkinson disease, postencephalitic.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
ÅëÇÕ°Ë»ö ¿Ï·á